These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 26847076)

  • 1. Battery drain in daily practice and medium-term projections on longevity of cardioverter-defibrillators: an analysis from a remote monitoring database.
    Boriani G; Ritter P; Biffi M; Ziacchi M; Diemberger I; Martignani C; Valzania C; Valsecchi S; Padeletti L; Gadler F
    Europace; 2016 Sep; 18(9):1366-73. PubMed ID: 26847076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Battery longevity in cardiac resynchronization therapy implantable cardioverter defibrillators.
    Alam MB; Munir MB; Rattan R; Flanigan S; Adelstein E; Jain S; Saba S
    Europace; 2014 Feb; 16(2):246-51. PubMed ID: 24099864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Device Longevity in a Contemporary Cohort of ICD/CRT-D Patients Undergoing Device Replacement.
    Zanon F; Martignani C; Ammendola E; Menardi E; Narducci ML; DE Filippo P; Santamaria M; Campana A; Stabile G; Potenza DR; Pastore G; Iori M; LA Rosa C; Biffi M
    J Cardiovasc Electrophysiol; 2016 Jul; 27(7):840-5. PubMed ID: 27094359
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longevity of implantable cardioverter-defibrillators for cardiac resynchronization therapy in current clinical practice: an analysis according to influencing factors, device generation, and manufacturer.
    Landolina M; Curnis A; Morani G; Vado A; Ammendola E; D'onofrio A; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2015 Aug; 17(8):1251-8. PubMed ID: 25976906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant Discrepancy Between Estimated and Actual Longevity in St. Jude Medical Implantable Cardioverter-Defibrillators.
    Doppalapudi H; Barrios J; Cuellar J; Gannon M; Yamada T; Kumar V; Maddox WR; Plumb VJ; Brown TM; McElderry HT
    J Cardiovasc Electrophysiol; 2017 May; 28(5):552-558. PubMed ID: 28181727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of extending device longevity on the long-term costs of implantable cardioverter-defibrillator therapy: a modelling study with a 15-year time horizon.
    Boriani G; Braunschweig F; Deharo JC; Leyva F; Lubinski A; Lazzaro C
    Europace; 2013 Oct; 15(10):1453-62. PubMed ID: 23696624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Battery longevity of implantable cardioverter-defibrillators and cardiac resynchronization therapy defibrillators: technical, clinical and economic aspects. An expert review paper from EHRA.
    Boriani G; Merino J; Wright DJ; Gadler F; Schaer B; Landolina M
    Europace; 2018 Dec; 20(12):1882-1897. PubMed ID: 29757390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of inappropriate anti-tachycardia pacing therapies and shocks by a novel suite of detection algorithms in heart failure patients with cardiac resynchronization therapy defibrillators: a historical comparison of a prospective database.
    Lunati M; Proclemer A; Boriani G; Landolina M; Locati E; Rordorf R; Daleffe E; Ricci RP; Catanzariti D; Tomasi L; Gulizia M; Baccillieri MS; Molon G; Gasparini M;
    Europace; 2016 Sep; 18(9):1391-8. PubMed ID: 26826135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The economic impact of battery longevity in implantable cardioverter-defibrillators for cardiac resynchronization therapy: the hospital and healthcare system perspectives.
    Landolina M; Morani G; Curnis A; Vado A; D'Onofrio A; Bianchi V; Stabile G; Crosato M; Petracci B; Ceriotti C; Bontempi L; Morosato M; Ballari GP; Gasparini M
    Europace; 2017 Aug; 19(8):1349-1356. PubMed ID: 27702861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased late complex device infections are determined by cardiac resynchronization therapy-defibrillator infection.
    Unsworth JD; Zaidi A; Hargreaves MR
    Europace; 2015 Nov; 17(11):1708-11. PubMed ID: 25883081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Facility-Level Variation and Clinical Outcomes in Use of Cardiac Resynchronization Therapy With and Without an Implantable Cardioverter-Defibrillator.
    Kramer DB; Normand ST; Volya R; Hatfield LA
    Circ Cardiovasc Qual Outcomes; 2018 Dec; 11(12):e004763. PubMed ID: 30562069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Battery longevity from cardiac resynchronization therapy defibrillators: differences between manufacturers and discrepancies with published product performance reports.
    Alam MB; Munir MB; Rattan R; Adelstein E; Jain S; Saba S
    Europace; 2017 Mar; 19(3):421-424. PubMed ID: 27009183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term outcomes after prophylactic ICD and CRT-D implantation in nonischemic patients: Analysis from a nationwide database of daily remote-monitoring transmissions.
    Forleo GB; Solimene F; Pisanò EC; Zanotto G; Calvi V; Pignalberi C; Maglia G; Iacopino S; Quartieri F; Biffi M; Caravati F; Curnis A; Capucci A; Senatore G; Santamaria M; Della Bella P; Manzo M; Giacopelli D; Gargaro A; D'Onofrio A
    J Cardiovasc Electrophysiol; 2019 Sep; 30(9):1626-1635. PubMed ID: 31165517
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Projected longevities of cardiac implantable defibrillators: a retrospective analysis over the period 2007-17 and the impact of technological factors in determining longevity.
    Paton MF; Landolina M; Billuart JR; Field D; Sibley J; Witte K
    Europace; 2020 Jan; 22(1):149-155. PubMed ID: 31407793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes in cardiac resynchronization therapy-defibrillator recipients 80 years of age and older.
    Adelstein EC; Liu J; Jain S; Schwartzman D; Althouse AD; Wang NC; Gorcsan J; Saba S
    Europace; 2016 Mar; 18(3):420-7. PubMed ID: 26487669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of multipoint pacing on projected battery longevity in cardiac resynchronization therapy. An IRON-MPP study sub-analysis.
    Forleo GB; Gasperetti A; Ricciardi D; Curnis A; Bertaglia E; Calò L; Pignalberi C; Calzolari V; Ribatti V; Lavalle C; Potenza D; Tondi L; Natale V; Notarstefano P; Viecca M; Morani G; Biffi M; Giammaria M; Zanon F; Santini L
    J Cardiovasc Electrophysiol; 2019 Dec; 30(12):2885-2891. PubMed ID: 31661172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicted longevity of contemporary cardiac implantable electronic devices: A call for industry-wide "standardized" reporting.
    Munawar DA; Mahajan R; Linz D; Wong GR; Khokhar KB; Thiyagarajah A; Kadhim K; Emami M; Mishima R; Elliott AD; Middeldorp ME; Roberts-Thompson KC; Young GD; Sanders P; Lau DH
    Heart Rhythm; 2018 Dec; 15(12):1756-1763. PubMed ID: 30063990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. "Real life" longevity of implantable cardioverter-defibrillator devices.
    Manolis AS; Maounis T; Koulouris S; Vassilikos V
    Clin Cardiol; 2017 Sep; 40(9):759-764. PubMed ID: 28543134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right Ventricular Pacing Increases Risk of Appropriate Implantable Cardioverter-Defibrillator Shocks Asymmetrically: An Analysis of the ALTITUDE Database.
    Cronin EM; Jones P; Seth MC; Varma N
    Circ Arrhythm Electrophysiol; 2017 Oct; 10(10):. PubMed ID: 29030379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival in Women Versus Men Following Implantation of Pacemakers, Defibrillators, and Cardiac Resynchronization Therapy Devices in a Large, Nationwide Cohort.
    Varma N; Mittal S; Prillinger JB; Snell J; Dalal N; Piccini JP
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28490521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.